To validate the RNA sequencing findings of S100A4, we conducted real-time PCR analysis and Western blotting assay and found that DHM inhibited S100A4 expression in cervical cancer cells in a concentration-dependent manner (Figure 3B,C). This evidence concerns the gene S100A4 and cervical cancer.